Genmab — Maj 2020

[E_L]

and then Jan says in the Q&A "Jan Van de Winkel More to come from Genmab in the coming time!":-D

[E_L]

US breaking their ATH from Tuesday
now

[bikube]

bibob - det er slutkursen fra d.16/3, du refererer til - laveste kurs den dag var 1082,50.

[Legolas23]

Ærgerlig lukkehandel

[Bisseministeren]

Svært at klage med en stigning på 4,5%

[Solsen]

89 point er ikke noget man ærgrer sig over

[gdn55]

Indtil videre et plus i denne uge på 45,00,
det er ok i min lille verden

[E_L]

they are really keen to promote their epco poster lol https://twitter.com/Genmab/status/1266021659988963328

[GeorgeBest]

E L - have you found a possibility for private investors to follow the presentation? Or should we as previous years wait for tweets from the oncologists?

[bibob]

Bikube . Ja det var.

[E_L]

i think the only way would be to buy a ticket to the conference... and i am not even sure what to expect from a 'virtual poster discussion'? it is not an oral
presentation

[GeorgeBest]

No they are apparantly prerecorded. There cant be much discussion...

[mobbyduck1]

Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis

[mobbyduck1]

https://ir.genmab.com/news-releases/news-release-details/genmab-announces-positive-topline-results-phase-iii-andromeda

[GeorgeBest]

Tak mobbyduck

[GeorgeBest]

hhmm - nul markedsreaktion

[E_L]

i think this calls for another quote from the Q&A "GeorgeBest Is there a change to see Andromeda presented at ASCO as a late breaker?
Jan Van de Winkel At this point we have not seen data from ANDROMEDA."

[SEACOP]

Hvor stort er markedet for Amyloidose ?

[SEACOP]

Sundhed.dk

(www.sundhed.dk)

[GeorgeBest]

Amyloidosis market US https://www.grandviewresearch.com/industry-analysis/amyloidosis-treatment-market